The Clinical Sequencing Evidence-Generating Research Consortium: Integrating Genomic Sequencing in Diverse and Medically Underserved Populations

The Clinical Sequencing Evidence-Generating Research (CSER) consortium, now in its second funding cycle, is investigating the effectiveness of integrating genomic (exome or genome) sequencing into the clinical care of diverse and medically underserved individuals in a variety of healthcare settings and disease states. The consortium comprises a coordinating center, six funded extramural clinical projects, and an ongoing National Human Genome Research Institute (NHGRI) intramural project. Collectively, these projects aim to enroll and sequence over 6,100 participants in four years.

Source: The American Journal of Human Genetics - September 6, 2018 Category: Genetics & Stem Cells Authors: Laura M. Amendola, Jonathan S. Berg, Carol R. Horowitz, Frank Angelo, Jeannette T. Bensen, Barbara B. Biesecker, Leslie G. Biesecker, Gregory M. Cooper, Kelly East, Kelly Filipski, Stephanie M. Fullerton, Bruce D. Gelb, Katrina A.B. Goddard, Benyam Hailu, Tags: Commentary Source Type: research